Abstract
The availability of costly safety measures against transfusion-transmissible infections forces Western countries to confront difficult ethical questions. How to decide about implementing such measures? When are such decisions justified? As a preliminary to addressing these questions, we assessed which concerns shape actual donor blood safety policymaking in five Western countries. Our qualitative study involved determining which issues had been discussed in advisory committee meetings and capturing these issues in general categories. Appropriate documents were identified in collaboration with local decision-making experts in Canada, Germany, the Netherlands, the United States, and the United Kingdom. The introduction of hepatitis B virus nucleic acid testing and selected measures against variant Creutzfeldt-Jakob disease, West Nile virus, and Q-fever were chosen as cases representing decision-making on safety measures with high costs and low or uncertain added safety. A broad inventory of concerns was established, including: 1) nine categories of advantages and disadvantages of candidate safety policies; 2) six kinds of difficulties in assessing risks and forecasting the effects of safety policies; 3) 13 decision-making princip...Continue Reading
References
Oct 14, 1998·Health Affairs·N Daniels, J Sabin
Oct 20, 2001·Philosophy & Public Affairs·Norman Daniels, James Sabin
Feb 19, 2002·Annals of Internal Medicine·Peter D WeinbergCharles L Bennett
Aug 31, 2002·Vox Sanguinis·M van HulstM J Postma
May 22, 2003·Transfusion·B R JacksonJ P AuBuchon
May 14, 2004·Medicine, Health Care, and Philosophy·Bert MolewijkJob Kievit
Apr 25, 2006·Seminars in Hematology·Michael A Stoto
Apr 25, 2006·Seminars in Hematology·Bruce Evatt
Sep 24, 2008·Blood·Harvey J Alter, Harvey G Klein
Nov 7, 2008·The New England Journal of Medicine·Robert Steinbrook
Apr 3, 2009·Bioethics·Barry Hoffmaster, Cliff Hooker
Mar 2, 2010·Vaccine·Hans HouwelingUNKNOWN National Immunisation Programme Review Committee of the Health Council of the Netherlands
Mar 25, 2011·Transfusion Medicine Reviews·Kumanan Wilson
Jul 26, 2011·Vox Sanguinis·J SteinD Devine
Sep 2, 2011·Transfusion·Barbara A Borkent-RavenBen A van Hout
Sep 17, 2013·Transfusion·Jay S EpsteinHarvey G Klein
Mar 13, 2014·Transfusion·Jay E MenitoveLouis M Katz
Apr 10, 2015·Transfusion·Brian CusterUNKNOWN Alliance of Blood Operators Risk-Based Decision-Making (RBDM) Initiative
Citations
Jan 20, 2016·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·B Pozzetto, O Garraud
Jan 16, 2016·Transfusion·Judie Leach Bennett
Feb 17, 2017·The American Journal of Bioethics : AJOB·Cristian Timmermann
Mar 23, 2017·The American Journal of Bioethics : AJOB·Koen KramerMarcel F Verweij
Feb 13, 2016·Journal of Medical Ethics·Marcel Verweij, Koen Kramer
Jul 6, 2019·Vox Sanguinis·Koen KramerHans L Zaaijer
Sep 21, 2018·Vox Sanguinis·Judie Leach Bennett, Dana V Devine
Jan 20, 2018·Journal of Risk Research·Kumanan WilsonJennifer Keelan